Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 5Fallopian Tube Neoplasms 5Breast Neoplasms 5Endometrial Neoplasms 4Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Carcinoma, Ovarian Epithelial 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solid Tumor, Unspecified, Adult 1Solid Tumor 1Small Cell Lung Carcinoma 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Mesothelioma, Malignant 1Leiomyosarcoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Adenocarcinoma, Clear Cell 1Adenocarcinoma of the Oesophagus 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1ATM Gene Mutation 1

Interventions

fludarabine 2Paclitaxel 2Nivolumab 2Bevacizumab 2rucaparib 1liposomal doxorubicin 1dostarlimab 1Sunitinib 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy 1Melphalan 1Ipilimumab 1Gemcitabine 1Erlotinib Hydrochloride 1Doxorubicin 1Dexamethasone 1Celecoxib 1Carboplatin 1Capecitabine 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Clear Cell × rucaparib × Clear all
NCT04227522 2024-11-15

MAMOC

North Eastern German Society of Gynaecological Oncology

Phase 3 Completed
42 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡